Blue Horseshoe Stocks: THC Explosion


Tenet Healthcare Corp. THC – Options Explode

We included a fresh options trading idea for THC in yesterday morning’s premarket report. The stock was exhibiting the characteristics of a potential bottom bounce play, and we signaled the THC Weekly $18-18.50 Calls to correlate with the possible rebound.

We got just what we were looking for, however, with far greater single-session figured than we could have imagined. The results were two of the best intraday gain possibilities that we’ve identified in 2019, tipping the scales with twenty-bagger status!

$18 Calls – Range: .10-2.14 – Max Gain: 2040%
$18.50 Calls – Range: .05-1.52 – Max Gain: 2940%

Updated Idea: THC Weekly $19.50-20 Calls 


PCT Ltd. PCTL 

For another quick update on PCTL, the OTC play we’ve been tracking, yesterday the stock registered new highs for the third time this week.

PCTL traded in a range from .017 to .029, for an intraday rip of 71% which also represented a total increase of 226% over our .0089 observed low following our initial alert on Monday morning.


Fresh Options Ideas:
SPY Weekly $301-302 Calls
BUD Weekly $99-101 Calls
MMM Weekly $185-190 Calls


Extended Watchist:
NOK, AZN, MYSZ, FCEL, LPTX, GHDX, UPS, DPW

Blue Horseshoe Stocks: More Hot Options Calls

Roku, Inc. ROKU

We signaled a range of ROKU calls yesterday morning after having tracked the stock itself to some nice gains in recent weeks. Despite a late pullback, ROKU produced an intraday run sufficient to propel four out of our five sets of highlighted contracts to some really nice single session moves.

With the exception of the 45.50’s which were too far out of the money, all of the targets yielded multi-bag gain opportunities on the day.

$43.50 Calls – Range: .34-.88 – Max Gain: 159%
$44 Calls – Range: .20-.70 – Max Gain: 250%
$44.50 Calls – Range: .23-.50 – Max Gain: 117%
$45 Calls – Range: .16-.48 – Max Gain: 200%

_____

Petroleo Brasileiro SA (Petrobras) PBR – Update

Just a quick update on the PBR Weekly $14.50-15.50 Calls that we signaled and rode to some nice gains earlier this week. We wanted to remind readers that those are still in play, and with PBR gapping up in the premarket once again, we’d expect to see new highs on our tracked contracts which have already produced multi-bag upswings this week.


Constellation Brands Inc. STZ

We are quite familiar with Constellation, with the beverage giant being headquartered in the same city as our home offices. STZ was building some decent momentum off of recent lows, until this morning’s earnings release, where some lackluster figures and guidance for 2019 are getting the stock crushed in the premarket. It’s testing new annual lows, which has us sniffing for a bargain.

We are taking a longer view on this company and signal a couple of sets of extended-term calls for what we expect to be a rebound from current conditions in the weeks and months ahead. We’re going to place the STZ 02/01 $150-157.50 Calls and the 04/18 $160-170 Calls on watch.


Extended Watchlist:
USAT, ACST, KNDI, MYSZ, FCEL,

Blue Horseshoe Stocks: PBR Options Recap & More

Petroleo Brasileiro SA (Petrobras) PBR – Recap

Yesterday morning, one of the primary focal points our premarket report was a pair of PBR options contracts, the PBR Weekly $14 & 14.50 Calls.

We cited the stock’s volatility and rapid rise over recent relative lows as the reasons for our interest, and despite yet another reversal for the markets in general, we got very solid single-session results for our PBR ideas. The $14’s traded up 95% from .21-.41, while the $14.50’s logged a double-bagger as they ran from  .05-.11, a gain of 120%

PBR is gapping up once again this morning, so we expect these figures to open up even higher. We will then be looking for a possible dip-and-rip scenario.


BioXcel Therapeutics, Inc. BTAI

We mentioned BTAI for the first time in yesterday morning’s extended watchlist, and got a solid first day performance from that stock as well, as it went in the books as the 2nd highest gainer on the Nasdaq for the session.

From a low of 4.00, BTAI went on to hit a high of 5.84, which worked out to a respectable 46% rise that also bucked the overall trend of the day. The move was facilitated by news that the company achieved positive human proof-of-concept data for acute treatment of agitation in patients with Alzheimer’s Disease, and other degenerative neural disorders. (>>View PR)


Extended Watchlist:
W, APU, ARGX, MYSZ, SN, XPO, EPZM, AMID, PROP, SING